Azstarys vs. Vyvanse: What’s the Difference?
Azstarys is a newer ADHD medication that shares some similarities with Vyvanse but works through a distinct combination approach — worth understanding if you’re comparing extended-release stimulant options with your provider.
What Vyvanse is
Vyvanse (lisdexamfetamine) is a prodrug — inactive until metabolized in the body into its active amphetamine form — producing a gradual, smoother onset and offset compared to immediate-release stimulants, which is part of why it’s commonly chosen for steady, all-day coverage.
What Azstarys is
Azstarys combines serdexmethylphenidate, a prodrug similar in concept to Vyvanse’s approach but built on methylphenidate rather than amphetamine, with a smaller amount of immediate-release dexmethylphenidate — designed to provide both a quicker onset and an extended, gradual release across the day.
Key differences
- Base compound: Vyvanse is amphetamine-based; Azstarys is methylphenidate-based
- Onset design: Azstarys combines an immediate-release component with its prodrug for a faster initial effect alongside extended coverage
- Individual response: patients who respond better to methylphenidate versus amphetamine compounds in general may find one option meaningfully more effective than the other
- Availability history: Azstarys is newer to market, with a shorter real-world usage track record than Vyvanse
Why the underlying compound (amphetamine vs. methylphenidate) matters
Beyond brand-specific formulation differences, many patients respond noticeably better to one of the two core stimulant families than the other — a pattern providers watch for across a patient’s medication history, since it can help predict which newer options within the same family might work well.
What determines the right choice
Your provider will consider your prior response to methylphenidate- or amphetamine-based medications, your specific symptom timing needs, and side-effect tolerance when discussing whether Azstarys, Vyvanse, or another option makes the most sense to try.
What to expect during a trial of either medication
Because both are relatively long-acting, extended-release options, your provider will likely want a few weeks to properly assess how well a given dose is working before making significant adjustments. Bringing specific, detailed notes about your daily experience to that follow-up helps make the most of the trial period. Neither option is inherently superior — the right choice depends entirely on how your specific body responds, which is something only a real trial period with your provider can actually determine.
Talk to a provider about your options
If you haven’t been evaluated yet, take a free 2-minute screening and start the conversation with a licensed provider.
